Trial intelligence / Profile preview

Butorphanol dose-finding for painless gastroscopy across age groups

ChiCTR2200066304Phase 4Not yet recruiting

Sponsor
Binzhou Medical University Hospital
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of butorphanol (3 arms), sponsored by Binzhou Medical University Hospital. Primary endpoints: Body movement occurrence and Cough occurrence. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

butorphanol

Beyond the preview

Go deeper on ChiCTR2200066304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call